NIH Grant Awards Fell to Six-Year Low
The agency has shifted its strategy to multiyear funding, leading to fewer individual awards in fiscal year 2026.
Updated on Oct. 3, 2026 in COVID-19
Live Poll
Should the federal government prioritize distributing research funds across a larger number of individual grants?
The National Institutes of Health issued 60,924 grant awards as of September 24, 2026, marking the lowest count in the past six fiscal years. This total represents an 11 percent decrease compared to the previous five-year average.
Why it matters
The reduction in total awards stems from a shift in federal strategy toward multiyear funding for individual projects rather than annual commitments. This change affects how researchers secure consistent financial support for their studies.
Official federal records show the NIH issued 60,924 grant awards as of September 24, which is 11 percent below the 68,561 annual average recorded over the prior five years. The final grant tally for fiscal year 2026 remains unresolved as the agency completes its end-of-year processing.
The players
National Institutes of Health
The primary agency of the United States government responsible for biomedical and public health research.
White House
The executive office of the President of the United States, which oversees federal policy and administration.
The details
The NIH is moving away from the model of funding projects on a one-year basis. Instead, the agency now commits several years of funding to individual awards at one time. This structural change explains the decline in the total number of distinct grants issued, even as total financial obligations reached $35.2 billion.
Timeline
September 23, 2026: The White House reportedly shelved a plan for a political commission with grant veto power.
September 24, 2026: The NIH reached a total of 60,924 grant awards.
September 30, 2026: The 2026 fiscal year concluded.
Health Landscape
This development reflects a strategic evolution in how the National Institutes of Health manages its annual funding obligations. By prioritizing multiyear commitments, the agency is adjusting the standard of care for research support within the broader U.S. biomedical landscape.
Changes in research funding impact the pace and scale of clinical trials available to the public. If you are participating in or monitoring a specific study, it is worth discussing with your doctor how federal research priorities might affect ongoing trial timelines and support.
The takeaway
While the total number of grants has decreased, total funding obligations remain level at $35.2 billion. Readers tracking clinical advancements should keep in mind that shifts in federal funding can influence the timing of future research developments.
Further reading
For more on the broader impacts of public health funding, visit COVID-19.
Source note: This article includes information reported by The Scientist.
Live Poll
Should the federal government prioritize distributing research funds across a larger number of individual grants?
